Product Images Rizatriptan Benzoate

Figure 1 displays estimated probabilities of obtaining headache relief (no or mild pain) following treatment with Rizatriptan Benzoate or placebo in four outpatient studies (Studies 1, 2, 3, and 4). The averages shown on the Kaplan-Meier plot are based on pooled data from these placebo-controlled trials. Patients not responding prior to two hours or receiving additional treatment are censored at two hours.*

The text describes a Kaplan-Meier plot of estimated probability of patients taking a second dose of Rizatriptan Benzoate tablets or other medication for migraines over the 24 hours following the initial dose of study treatment in pooled Studies 1, 2, 3, and 4. The plot shows the percentage of patients taking a second dose at different time intervals up to 24 hours post-dose. Patients who had no response to the initial dose and those who had a headache response at 2 hours are included in the plot. The plot is based on data obtained from 4 placebo-controlled outpatient clinical trials. The text also indicates that remedication was not allowed within 2 hours post-dose and patients not using additional treatments were censored at 24 hours.*

This appears to be a partial data table or graph. It shows the percentage (with a 95% confidence interval) at different time intervals (0, 2, 4, 6, 8, 24 hours) after taking Rizatriptan Benzoate orally disintegrating tablets compared to a placebo. However, without further context or information, it is not possible to provide a more specific description or interpretation of the data.*

This is the description of a prescription drug named Rizatriptan Benzoate 10mg in the form of 12 tablets. It contains instructions on how to store it and each tablet contains 14.53 mg of rizatriptan benzoate USP equivalent to rizatriptan 10 mg. The tablets are pale pink-colored, circular, flat beveled-edge uncoated tablets debossed with ‘rizatriptan’ on one side and ‘14’ on the other side. The drug is labeled by Proficient Rx LP, Thousand Oaks, CA, and manufactured by Aurobindo Pharma Limited Hyderabad-500 038, India. The lot number of the drug is 00000, and the expiration date is 00/00/00.*